Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04985695

Influence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy

Randomized controlled trial (1:1) in two parallel groups, multicentric, open-label, comparing two locoregional anesthesia (LRA) techniques as integral parts of multimodal analgesia: the control group will benefit from epidural anesthesia, while the experimental group will benefit from bilateral placement of catheters in the sheath of the rectus abdominis muscles.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHR Metz Thionville Hopital de Mercy, Metz, Moselle, France

Loading trial locations.

About this study

Implementation of fast-track rehabilitation surgery was essential in patient care, specially in oncological point.

In this way, uses of the technic of local anesthesia, include epidural analgesia, was essential, but this one is associated with few complications. Emergence of new technic of anesthesia with a comparative analgesia and without side effects should be a better alternative than epidural analgesia. Thus, bilateral rectus sheath block has been reported to be effective in management of postoperative pain.

After signing of the informed consent, two postoperative analgesia techniques were investigated in patients undergoing midline laparotomy.

The main objective of this study is to compare the influence of analgesic technique on the Quality of Recovery-15 score. The study design was a prospective, randomized trial with 2 parallel arms (epidural analgesia vs bilateral rectus sheath block).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA (American Society of Anesthesiologists) Class I-IV adult, with programmed midline laparotomy
  • Have given an informed written consent
  • Able to read and understand french language
  • Affiliation to a social security system

Exclusion criteria

  • Local anesthesic contraindication (allergy, porphyria, haemolytic anaemia, uncontrolled epilepsy, or severe cardiac conduction disorders) or TEA (coagulation disorders, progressive neurological disease, or severe spinal disorder),
  • Epidural analgesia contraindication
  • With impossibility to set up bilateral rectus sheath block
  • Participation in another clinical study
  • Pregnant women
  • Patients deprived of their liberty by a judicial or administrative decision,
  • Patients undergoing psychiatric care under articles L.3212-1 and L.3213-1 of the French Public Health Code

Treatment and study plan

Epidural analgesia

Drug

All patients received local anesthesia (3-5 ml of 2% Lidocaine). During the preoperative induction of anaesthesia a catheter was inserted 4cm into the epidural space. The catheter will be load during the intervention (0.1 ml/kg/h). In postoperative situation, a patient controlled epidural analgesia was introduced with a debit adapted to the arterial pressure.

Bilateral rectus sheath block

Drug

Bilateral rectus sheath block was performed Under general anesthesia and with ultrasound guidance. Rectus sheath block was inserted on each side of the abdomen. All patients received ropivacaine through elastomeric pump

Laparotomy

Procedure

A midline sub or supra umbilical laparotomy or xypho-pubian laparotomy

Primary outcomes

  1. Change in total QoR-15 score

    Time frame: Postoperative day 2

    The Quality of Recovery-15 (QoR-15) included five dimensions: physical comfort, emotional state, pain, psychological support and physical independence. Each item was assessed using an 11-point numerical rating scale (for positive itel, 0="none of the time" to 10="all the time"; for negative items the scoring was reversed).

Secondary outcomes

  1. Change in total Qor-15 score on postoperative days 1 and 3 compared to the day before surgery

    Time frame: Postoperative days 1, and 3

    The Quality of Recovery-15 (QoR-15) included five dimensions: physical comfort, emotional state, pain, psychological support and physical independence. Each item was assessed using an 11-point numerical rating scale (for positive itel, 0="none of the time" to 10="all the time"; for negative items the scoring was reversed).

  2. Efficacy of postoperative analgesia

    Time frame: Day 0 and Postoperative days 1, 2, 3 and 30

    The efficacy of postoperative analgesia was compared between the two groups with the visual analog scale (VAS). The VAS intensity rating consisted of a 100-mm line with the end points no pain (0 mm) and worst pain (100 mm). Study participants were asked to evaluated with a mark on the line their current pain intensity. The difference between each postoperative treatment VAS score was compared.

  3. Impact of arterial hypotension

    Time frame: Postoperative days 1, 2 and 3

    The impact of arterial hypotension was compared between the two groups with the arterial pressure value before and after laparotomy

  4. Impact of orthostatic hypotension

    Time frame: Postoperative days 1, 2 and 3

    The impact of orthostatic hypotension was compared between the two groups with the arterial pressure value before and after surgery.

  5. Occurrence of nausea and/or vomiting

    Time frame: Day 0, Postoperative days 1, 2 and 3 and at hospital discharge up to 30 days

    The effect of analgesic technique on nausea and/or vomiting is calculated on the basis of the number of anti-vomiting prescribed.

  6. Postoperative complications link to analgesic technique

    Time frame: Postoperative days 1, 2 and 3

    Number of postoperative complication in both groups

  7. The length of stay

    Time frame: at hospital discharge up to 30 days

    Comparison of the length of stay between the two groups

  8. Return to normal bowel function

    Time frame: Postoperative days 1, 2 and 3 and at hospital discharge up to 30 days

    Delay in hours to promotes normal digestive activity. The included the times to recovery the first bowel sounds, first anal exhaust and defecation.

  9. The quantity of morphine or equivalent

    Time frame: Day 0 and Postoperative days 1, 2 and 3

    The quantity of morphine or equivalent administered during the 48 first hours in both groups

  10. Urinary catheterization

    Time frame: at hospital discharge up to 30 days

    The time during which the patients are taking recourse to postoperative urinary catheterization

  11. Total distance covered

    Time frame: Postoperative days 1, 2 and 3

    Compare the impact of postoperative analgesia in Walking distance (meter) within days following the operation

  12. Failure to set up a catheter

    Time frame: Postoperative day 1

    Number of Failure to delivery catheter in both techniques

  13. The time until the first raised

    Time frame: Postoperative days 1, 2 and 3 and at hospital discharge up to 30 days

    Delay before the first raised in hours

  14. Impact of premature discontinuation of local anesthetic perfusion

    Time frame: on day 0

    Number of premature discontinuation of local anesthetics

  15. Patient satisfaction and need for further consultation

    Time frame: at hospital discharge up to 30 days and on postoperative day 30

    Satisfaction questionnaire

Study contacts

Contact information is provided by the study sponsor or research team.

Arpiné EL NAR, PhD

CONTACT

[email protected]

0033387557766

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Régional Metz-Thionville

Other

Registry information

Official study title

Influence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy: Comparison Between Thoracic Epidural Anesthesia Versus Bilateral Rectus Sheath Block

Acronym: QORRECTCATH

Important dates

Study start
2021
Primary completion
2028
Study completion
2029
First posted
Aug 2, 2021
Registry last updated
Dec 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.